Overview of Dr. Cobleigh
Dr. Melody Cobleigh is an oncologist in Chicago, IL and is affiliated with multiple hospitals in the area, including Rush University Medical Center, Rush Oak Park Hospital, and Loyola University Medical Center. She received her medical degree from Rush Medical College of Rush University Medical Center and has been in practice 42 years. Dr. Cobleigh accepts several types of health insurance, listed below. She is one of 58 doctors at Rush University Medical Center and one of 19 doctors at Rush Oak Park Hospital who specialize in Oncology. She has more than 100 publications and over 500 citings.
Office
1725 W Harrison St
Suite 1010
Chicago, IL 60612
Education & Training
- Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1979 - 1981
- Rush University Medical CenterResidency, Internal Medicine, 1977 - 1979
- Rush University Medical CenterResidency, Internal Medicine, 1976 - 1976
- Rush Medical College of Rush University Medical CenterClass of 1975
Certifications & Licensure
- IL State Medical License 1977 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2003-2017
- Chicago Magazine: Top Doctors Castle Connolly, 2004, 2006, 2008, 2010, 2012, 2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer Start of enrollment: 1995 Oct 01
- Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer Start of enrollment: 2000 Nov 28
- Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer Start of enrollment: 2002 Jan 29
- Join now to see all
Publications & Presentations
PubMed
- 2321 citationsPaclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast CancerKathy D. Miller, Molin Wang, Julie Gralow, Maura N. Dickler, Melody A. Cobleigh
The New England Journal of Medicine. 2007-12-27 - 42 citationsShould multicentric disease be an absolute contraindication to the use of breast-conserving therapy?William F. Hartsell, D. Recine, Katherine L. Griem, Melody A. Cobleigh, Thomas R. Witt
International Journal of Radiation Oncology, Biology, Physics. 1994-08-30 - 194 citationsGenetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African an...Rita Nanda, L. Philip Schumm, Shelly Cummings, James D. Fackenthal, Lise Sveen
JAMA. 2005-10-19
Journal Articles
- Can Chimerism Explain breast/ovarian Cancers in BRCA Non-Carriers from BRCA-Positive Families?Lydia Usha, Melody Cobleigh, PLoS One
Press Mentions
- Dr. Janet Wolter, Oncologist and Cancer Researcher at Rush, DiesFebruary 9th, 2020
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPOFirst Health PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: